Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity

v3.20.4
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Preferred Stock
Convertible Preferred Stock
Common stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balance at Dec. 31, 2018 $ 2,728 $ 0 $ 4 $ 173,962 $ (92) $ (171,146)
Balance (in shares) at Dec. 31, 2018   0 4,198      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (12,132)         (12,132)
Issuance of common stock under:            
Equity financing, net 12,444   $ 2 12,442    
Equity financing, net (in shares)     1,534      
Equipois sales earn-out 22     22    
Equipois sales earn-out (in shares)     1      
Equity incentive plan 228     228    
Equity incentive plan (in shares)     12      
Matching contribution to 401(k) plan 191     191    
Matching contribution to 401(k) plan (in shares)     9      
In lieu of employee cash bonus 919     919    
In lieu of cash compensation / bonus (in shares)     41      
Stock-based compensation 2,255     2,255    
Foreign currency translation adjustments 142       142  
Balance at Dec. 31, 2019 6,797 $ 0 $ 6 190,019 50 (183,278)
Balance (in shares) at Dec. 31, 2019   0 5,795      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (15,825)         (15,825)
Issuance of common stock under:            
Equity financing, net 7,082   $ 2 7,080    
Equity financing, net (in shares)     1,748      
Equity incentive plan (in shares)     35      
Exercise of warrants 7,310     7,310    
Exercise of warrants (in shares)     723      
Matching contribution to 401(k) plan 155     155    
Matching contribution to 401(k) plan (in shares)     26      
In lieu of employee cash bonus 50     50    
In lieu of cash compensation / bonus (in shares)     9      
Shares issued as a result of rounding due to reverse-stock split     13      
Issuance of warrants (2,322)     (2,322)    
Stock-based compensation 2,084     2,084    
Foreign currency translation adjustments (897)       (897)  
Balance at Dec. 31, 2020 $ 4,434 $ 0 $ 8 $ 204,376 $ (847) $ (199,103)
Balance (in shares) at Dec. 31, 2020   0 8,349